Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer
Authors
Keywords
-
Journal
PANCREAS
Volume 50, Issue 6, Pages 827-833
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-08-05
DOI
10.1097/mpa.0000000000001857
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FOLFIRINOX in patients with peritoneal carcinomatosis from pancreatic adenocarcinoma: a retrospective study
- (2019) E. Bonnet et al. Current Oncology
- Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma
- (2019) Anouk E.J. Latenstein et al. EUROPEAN JOURNAL OF CANCER
- Defining the molecular pathology of pancreatic body and tail adenocarcinoma
- (2018) S. B. Dreyer et al. BRITISH JOURNAL OF SURGERY
- Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis
- (2018) Jihoon Kang et al. INVESTIGATIONAL NEW DRUGS
- Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: A population-based study
- (2018) Lydia G. M. van der Geest et al. Cancer Medicine
- Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis
- (2018) Tara M. Mackay et al. EUROPEAN JOURNAL OF CANCER
- Early detection of pancreatic cancer: Where are we now and where are we going?
- (2017) Bin Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- Peritoneal carcinomatosis from unusual cancer origins: Is there a role for hyperthermic intraperitoneal chemotherapy?
- (2016) C. Honoré et al. Journal of Visceral Surgery
- Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5
- (2015) Côme Lepage et al. EUROPEAN JOURNAL OF CANCER
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma
- (2015) Dietrich A. Ruess et al. BMC Surgery
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- Imaging diagnosis of pancreatic cancer: A state-of-the-art review
- (2014) Eun Sun Lee WORLD JOURNAL OF GASTROENTEROLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence, Prognosis, and Possible Treatment Strategies of Peritoneal Carcinomatosis of Pancreatic Origin
- (2012) Irene Thomassen et al. PANCREAS
- Pancreatic Adenocarcinoma: Complete Tumor Extirpation Improves Survival Benefit Despite Larger Tumors for Patients Who Undergo Distal Pancreatectomy and Splenectomy
- (2011) Paul Toomey et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Pancreatic cancer in the UK
- (2011) The Lancet LANCET
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now